Q4/2024 12/31/2024 EPS 5.310 ZacksConsensus 5.030 ActVsEst 0.280 - Beat
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Amgen (AMGN) Rises As Market Takes a Dip: Key Facts [Yahoo! Finance]Yahoo! Finance
- RFK Jr. May Want To Ban Prescription Drug Ads, But Can He? [Forbes]Forbes
- Global Cancer Research Community Gathers to Share Breakthroughs at The Mark Foundation's 2025 Scientific Symposium [Yahoo! Finance]Yahoo! Finance
- UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASEPR Newswire
- Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now [Yahoo! Finance]Yahoo! Finance
AMGN
Earnings
- 2/4/25 - Beat
AMGN
Sec Filings
- 4/2/25 - Form ARS
- 3/19/25 - Form 4
- 3/19/25 - Form 4
- AMGN's page on the SEC website